Columbia, SC6 Active Studies

Interstitial Lung Disease Clinical Trials in Columbia, SC

Find 6 actively recruiting interstitial lung disease clinical trials in Columbia, SC. Connect with local research sites and explore new treatment options.

6
Active Trials
5
Sponsors
739
Enrolling

Recruiting Interstitial Lung Disease Studies in Columbia

About Interstitial Lung Disease Clinical Trials in Columbia

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 6 interstitial lung disease clinical trials recruiting participants in Columbia, SC. These studies are seeking a combined 739 participants. Research is being sponsored by Russell McCulloh, MD, UConn Health, University of South Carolina and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Columbia — FAQ

Are there interstitial lung disease clinical trials in Columbia?

Yes, there are 6 interstitial lung disease clinical trials currently recruiting in Columbia, SC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Columbia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbia research site will contact you about next steps.

Are clinical trials in Columbia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbia studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 6 active trials in Columbia are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated July 13, 2026 from ClinicalTrials.gov